|
HY-10015-10mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-100mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-25mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-5mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-10015-50mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-100421-1mg
|
MedChemexpress LLC
|
CPI-455 [CAS 1628208-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100421-10mg
|
MedChemexpress LLC
|
CPI-455 [CAS 1628208-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100421-100mg
|
MedChemexpress LLC
|
CPI-455 [CAS 1628208-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100421-25mg
|
MedChemexpress LLC
|
CPI-455 [CAS 1628208-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100421-5mg
|
MedChemexpress LLC
|
CPI-455 [CAS 1628208-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100421-50mg
|
MedChemexpress LLC
|
CPI-455 [CAS 1628208-23-0]
|
|
Cancer-programmed cell death
|
|
|
HY-100554-10mg
|
MedChemexpress LLC
|
BMY 7378 [CAS 21102-95-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100613-10mg
|
MedChemexpress LLC
|
MONNA [CAS 1572936-83-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100613-25mg
|
MedChemexpress LLC
|
MONNA [CAS 1572936-83-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100613-5mg
|
MedChemexpress LLC
|
MONNA [CAS 1572936-83-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100613-50mg
|
MedChemexpress LLC
|
MONNA [CAS 1572936-83-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10081-10mg
|
MedChemexpress LLC
|
GS-6201 [CAS 752222-83-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10081-100mg
|
MedChemexpress LLC
|
GS-6201 [CAS 752222-83-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10081-25mg
|
MedChemexpress LLC
|
GS-6201 [CAS 752222-83-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10081-5mg
|
MedChemexpress LLC
|
GS-6201 [CAS 752222-83-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10081-50mg
|
MedChemexpress LLC
|
GS-6201 [CAS 752222-83-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100849-1mg
|
MedChemexpress LLC
|
JAK 3i [CAS 1918238-72-8]
|
|
|
|
|
HY-100959-50mg
|
MedChemexpress LLC
|
3,5-Dinitrocatechol [CAS 7659-29-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101029-1mg
|
MedChemexpress LLC
|
MBM-55 [CAS 2083622-09-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-101029-10mg
|
MedChemexpress LLC
|
MBM-55 [CAS 2083622-09-5]
|
|
Cancer-Kinase/protease
|
|
